Cancer prevention: epigenetics steps up to the plate.
Issa
Jean-Pierre
JP
Department of Leukemia and Epigenetics Center, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX 77030, USA. jpissa@mdanderson.org
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D018890:Chemoprevention / Q000379:methods / Q000639:trends*; D003562:Cytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000037:antagonists & inhibitors; D019175:DNA Methylation / Q000502:physiology; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D044127:Epigenesis, Genetic / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000235:genetics* / Q000517:prevention & control*
D000964:Antimetabolites, Antineoplastic; D004791:Enzyme Inhibitors; D003562:Cytidine; D000077209:Decitabine; C009131:pyrimidin-2-one beta-ribofuranoside; D004248:DNA (Cytosine-5-)-Methyltransferases; D001374:Azacitidine